Risk of share dilution from the exercise of stock options
First written in FY2022. 8 of 10 entries say "Materialised", first in FY2023-Q1. Latest entry: FY2026.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026MaterialisedAnnual report
「The increase of 1,800 shares during the consolidated fiscal year resulted from the exercise of stock options.」
A total of 1,800 shares were issued through the exercise of stock options during the consolidated fiscal year, and share issuance resulting in dilution continued. - FY2026-H1MaterialisedAnnual report
「From 1 October 2025 to 31 October 2025, the exercise of stock acquisition rights increased the total shares issued by 1,200 shares and increased capital and capital surplus by ¥0 million each.」
A total of 600 shares were issued through the exercise of stock acquisition rights during the interim period, followed by a further 1,200 shares in October 2025 before the filing date. Share issuance resulting in dilution has continued. - FY2025Increase in Potential Shares, Decline in PercentageAnnual report
「As of the end of the month preceding the month in which this document was filed, the number of potential shares from stock acquisition rights was 297,000, equivalent to 4% of the total shares issued.」
The number of potential shares increased from the previously reported 282,300 to 297,000, while the ratio to total shares issued declined from 8.0% to 4%. - FY2025-H1MaterialisedAnnual report
「From 1 October 2024 to 31 October 2024, the exercise of stock acquisition rights increased the total shares issued by 3,600 shares and increased capital and capital surplus by ¥0 million each.」
A total of 2,400 shares were issued through the exercise of stock acquisition rights during the interim period, followed by a further 3,600 shares in October 2024. Share issuance resulting in dilution has continued. - FY2024-Q3MaterialisedAnnual report
「1 October 2023 to 31 December 2023 16,200 This resulted from the exercise of stock acquisition rights.」
A total of 16,200 shares were issued through the exercise of stock acquisition rights during the third quarter accounting period. A further 63,600 shares were issued in January 2024, and share issuance resulting in dilution has continued. - FY2024-Q1MaterialisedAnnual report
「1 April 2023 to 30 June 2023」
A total of 12,600 shares were issued through the exercise of stock acquisition rights during the first quarter, and share issuance resulting in dilution has continued. - FY2023-Q3MaterialisedAnnual report
「This was due to the exercise of stock acquisition rights.」
A total of 3,300 shares were issued through the exercise of stock acquisition rights from October to December 2022. Actual share issuance resulting in dilution has continued. - FY2023-Q2MaterialisedAnnual report
「This was due to the exercise of stock acquisition rights.」
A total of 48,900 shares were issued through the exercise of stock acquisition rights from July to September 2022, and a further 300 shares were issued in October. Actual share issuance resulting in dilution has continued. - FY2023-Q1MaterialisedAnnual report
「This was due to the exercise of stock acquisition rights.」
The number of shares issued increased by 20,400 during the first quarter through the exercise of stock acquisition rights and increased by a further 31,200 in July 2022. Actual shares have been issued through the exercise of potential shares. - FY2022First statedAnnual report
「As of the end of the month preceding the month in which this document was filed, the number of potential shares from stock acquisition rights was 282,300, equivalent to 8.0% of the total shares issued.」
The potential dilution from 282,300 shares under the incentive scheme for officers and employees, equivalent to 8.0% of the total shares issued, is disclosed.